Metrics as of 10/16/2026, 08:48 AM (Berlin time), refresh in progress.
Aptamer Group Stock
Aptamer Group plc
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United Kingdom
- CEO
- Arron Craig Tolley
- Employees
- 30
- Market cap
- £11 M
- IPO
- 22/12/2021
Aptamer Group plc, an international company headquartered in York, United Kingdom, specializes in providing advanced binders for applications spanning research, diagnostics, and therapeutics. Their innovative binder technology is engineered to resolve challenges often associated with traditional molecular tools, such…
Aptamer Group stock: price history
1D
+0.0%
1W
+0.0%
1M
-4.4%
6M
-48.0%
YTD
-69.9%
1Y
-66.7%
2Y
+58.5%
5Y
–
10Y
–
Next earnings date
Next earnings date
01/04/2027 (in 166 days)
Volatility around earnings
~43% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Aptamer Group
Aptamer Group stock metrics
P/E
-4.59
P/B
1.49
EV/EBITDA
-2.72
RETURN ON EQUITY
-12.4%
NET MARGIN
-99.7%
DEBT/EQUITY
0.03
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
63.0%
FLOAT SHARES
2,183,575,898
AVG. DAILY VOLUME (30D)
5,625,210
Comparable stocks
Frequently asked questions about Aptamer Group stock
What does Aptamer Group do?
Aptamer Group plc is a company in the Healthcare sector, Biotechnology industry, headquartered in United Kingdom.
The CEO is Arron Craig Tolley, the company employs around 30 people.
The IPO was on 22/12/2021; the stock trades on LSE under the ticker APTA.L.
When does Aptamer Group report next?
The next earnings date is 01/04/2027.
Around past earnings, price swings were roughly -43% stronger than usual.
Does Aptamer Group pay a dividend?
No, Aptamer Group currently does not pay a dividend.
Which stocks are comparable to Aptamer Group?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Aptamer Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess Aptamer Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.